Dhanuka Realty Ltd. News and Updates

Keep track of all breaking news on Dhanuka Realty Ltd. from all sources in a single place.

31 May 2025

29.60

-1.99%

Novo Nordisk diabetes / weightloss drug semaglutide locked in a legal tangle with DRL

Business Line

Several Indian drugmakers wait in the wings to make this drug popular as Ozempic/Wegovy -as some patents expire next year

Dhanuka Realty Ltd.

13 Apr 2025

29.60

-1.99%

DRL trims workforce costs by 25% amid Revlimid-linked margin strain

Business Standard

Company hired 6,281 people in FY24; total 26,343 people employed globally

Dhanuka Realty Ltd.

10 Aug 2023

29.60

-1.99%

At multi-year highs: DRL among 5 stocks witnessing 5-year swing high breakouts

Economic Times

A 5-year swing high represents the highest price a stock has reached within a five-year timeframe. This level acts as a significant resistance point where the price has historically struggled to go beyond

Dhanuka Realty Ltd.

02 Aug 2023

29.60

-1.99%

At multi-year highs: DRL among 7 stocks that saw 5-year swing high breakout

Economic Times

Dhanuka Realty Ltd.

19 Aug 2022

29.60

-1.99%

Mahindra to unveil Scorpio Classic's price tomorrow; check details here

Business Standard

According to a media report, the new and updated SUV comes with a restyled front bumper, Mahindra's 'twin-peaks' logo, and new LED DRLs

Dhanuka Realty Ltd.

28 Jan 2022

29.60

-1.99%

DRL Q3 Results Preview: Profit may grow 25% YoY; margin likely to fall

Economic Times

Edelweiss sess profit rising 26.5 per cent YoY to Rs 780 crore. It sees sales rising 12.2 per cent YoY to Rs 5,531 crore. The brokerage sees Ebitda margin falling 14 basis points YoY to 22.7 per cent, with input cost headwinds partly compensated by plateauing SG&A investments.

Dhanuka Realty Ltd.

21 Jan 2022

29.60

-1.99%

Viral vaccines, vector platforms may become new growth areas: DRL chief

Business Standard

In a Q&A, the chairman of Dr Reddy's Laboratories dwells, among other things, on the draft R&D policy and the first-ever Global Innovation Summit of the pharma sector held last November

Dhanuka Realty Ltd.

01 Nov 2021

29.60

-1.99%

DRL's many pluses negated by regulatory hit

Economic Times

The operating margin of 27% has been above the company's long term guidance of 25%. However, the good performance was dented after the company disclosed being issued Form 483 containing eight observations from US drug regulator USFDA for two of its facilities at Duvvada in Andhra Pradesh. After surging over 5% following the results, the DRL stock finally closed at a gain of 2%.